Epidemiology and biology of relapse after stem cell transplantation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidemiology and biology of relapse after stem cell transplantation
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-04-13
DOI
10.1038/s41409-018-0171-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
- (2017) Jun Liu et al. Journal of Hematology & Oncology
- Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia
- (2017) A Elder et al. LEUKEMIA
- Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
- (2017) Thomas Kammertoens et al. NATURE
- Changing Trends of Unrelated Umbilical Cord Blood Transplantation for Hematologic Diseases in Patients Older than Fifty Years: A Eurocord-Center for International Blood and Marrow Transplant Research Survey
- (2016) Hanadi Rafii et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking
- (2016) Friederike Braig et al. BLOOD
- Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
- (2016) P Tsirigotis et al. BONE MARROW TRANSPLANTATION
- Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia
- (2016) Sarah Ebinger et al. CANCER CELL
- Genetically distinct leukemic stem cells in human CD34−acute myeloid leukemia are arrested at a hemopoietic precursor-like stage
- (2016) Lynn Quek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance
- (2016) J Weiland et al. LEUKEMIA
- Loss of the mismatched human leukocyte antigen haplotype in two acute myelogenous leukemia relapses after haploidentical bone marrow transplantation with post-transplantation cyclophosphamide
- (2016) S R McCurdy et al. LEUKEMIA
- HLA mismatching as a strategy to reduce relapse after alternative donor transplantation
- (2016) Katharina Fleischhauer et al. SEMINARS IN HEMATOLOGY
- The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen
- (2015) Alvaro Urbano-Ispizua et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells
- (2015) Nicoletta Cieri et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment
- (2015) R. Polak et al. BLOOD
- Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
- (2015) A Hamdi et al. BONE MARROW TRANSPLANTATION
- Modern approaches to HLA-haploidentical blood or marrow transplantation
- (2015) Christopher G. Kanakry et al. Nature Reviews Clinical Oncology
- Loss of Mismatched HLA on the Leukemic Blasts of Patients With Relapsed Lymphoid Malignancies Following Bone Marrow Transplantation From Related Donors With HLA Class II Mismatches in the Graft Versus Host Direction
- (2015) Koichi Hirabayashi et al. PEDIATRIC BLOOD & CANCER
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Loss of Mismatched HLA Detected in the Peripheral Blood of an AML Patient who Relapsed After Haploidentical Hematopoietic Stem Cell Transplantation
- (2015) Borae G. Park et al. Annals of Laboratory Medicine
- One million haemopoietic stem-cell transplants: a retrospective observational study
- (2015) Alois Gratwohl et al. Lancet Haematology
- Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
- (2014) P. Armand et al. BLOOD
- Leukemia Propagating Cells Rebuild an Evolving Niche in Response to Therapy
- (2014) Cai-Wen Duan et al. CANCER CELL
- Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
- (2014) M. Boyiadzis et al. CLINICAL CANCER RESEARCH
- Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement
- (2014) M Bardini et al. LEUKEMIA
- Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation
- (2014) L Crucitti et al. LEUKEMIA
- Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors
- (2014) J Peccatori et al. LEUKEMIA
- Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma
- (2013) Luciano J. Costa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Trends in Use of and Survival after Autologous Hematopoietic Cell Transplantation in North America, 1995-2005: Significant Improvement in Survival for Lymphoma and Myeloma during a Period of Increasing Recipient Age
- (2013) Philip L. McCarthy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Relapse or Eradication of Cancer Is Predicted by Peptide-Major Histocompatibility Complex Affinity
- (2013) Boris Engels et al. CANCER CELL
- Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
- (2013) E. H. Warren et al. TISSUE ANTIGENS
- Graft-versus-Host Disease Induced Graft-versus-Leukemia Effect: Greater Impact on Relapse and Disease-Free Survival after Reduced Intensity Conditioning
- (2012) Daniel Weisdorf et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT
- (2012) C. Toffalori et al. BLOOD
- Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations
- (2012) Klaus Rehe et al. EMBO Molecular Medicine
- Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia
- (2012) Luca Vago et al. SEMINARS IN ONCOLOGY
- Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation
- (2012) Friedrich Stölzel et al. TRANSPLANTATION
- The Origin and Nature of Tightly Clustered BTG1 Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution
- (2012) Esmé Waanders et al. PLoS Genetics
- Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation
- (2011) Miguel Waterhouse et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment
- (2011) M. Schmitz et al. BLOOD
- Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
- (2011) F. W. van Delft et al. BLOOD
- Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia
- (2011) Nicolas Goardon et al. CANCER CELL
- Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy
- (2011) Yordanos Tesfai et al. LEUKEMIA RESEARCH
- Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
- (2011) Faiyaz Notta et al. NATURE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation
- (2010) I. B. Villalobos et al. BLOOD
- Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
- (2010) C. O'Keefe et al. BLOOD
- Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
- (2010) B. Jena et al. BLOOD
- Bystander killing of cancer requires the cooperation of CD4+and CD8+T cells during the effector phase
- (2010) Andrea Schietinger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
- (2010) Ted A. Gooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma
- (2009) H Schwindt et al. LEUKEMIA
- Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
- (2009) Luca Vago et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties
- (2008) Christoph le Viseur et al. CANCER CELL
- IFN-γ– and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
- (2008) Bin Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth
- (2008) S. Purhonen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
- (2008) C. G. Mullighan et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started